Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$9,109,141
+$437,388 QoQ
Shares Held
35,867
+1.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.66%
of 13F equity value
Holder Rank
#1,173
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Columbus Macro, LLC holds $32,705,466 across 7 Drug Manufacturers - General names. JNJ ranks #1 (27.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
35,867 | $9,109,141 | |
| 2 | ABBV |
AbbVie Inc.
|
30,821 | $7,755,796 | |
| 3 | AMGN |
Amgen Inc
|
20,153 | $7,297,804 | |
| 4 | AZN |
Astrazeneca PLC
|
15,923 | $3,019,319 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
21,700 | $2,741,578 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
42,034 | $2,421,999 | |
| 7 | LLY |
ELI LILLY & Co
|
300 | $359,829 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,109,141 | 35,867 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $8,671,753 | 35,476 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $7,191,512 | 34,750 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $6,622,275 | 35,715 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $5,409,641 | 35,415 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $5,619,156 | 33,883 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $2,386,374 | 16,501 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,682,344 | 10,381 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,542,426 | 10,553 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,331,485 | 8,417 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,360,659 | 8,681 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $1,369,665 | 8,794 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $1,014,968 | 6,132 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $1,118,945 | 7,219 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,267,640 | 7,176 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,192,854 | 7,302 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $1,302,390 | 7,337 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $1,313,451 | 7,411 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,208,609 | 7,065 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $1,207,374 | 7,476 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $1,255,483 | 7,621 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,258,756 | 7,659 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,400,209 | 8,897 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,454,706 | 9,771 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $583,473 | 4,149 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $713,740 | 5,443 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||